- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-2-mer
- Ligands
- 13 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 27 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.15: 2 residues within 4Å:- Chain A: D.210, N.212
Ligand excluded by PLIPNAG.16: 2 residues within 4Å:- Chain A: P.446, N.449
Ligand excluded by PLIPNAG.17: 1 residues within 4Å:- Chain A: N.713
Ligand excluded by PLIPNAG.18: 1 residues within 4Å:- Chain A: N.787
Ligand excluded by PLIPNAG.19: 2 residues within 4Å:- Chain A: A.932, N.936
Ligand excluded by PLIPNAG.20: 3 residues within 4Å:- Chain A: V.1192, N.1193, M.1197
Ligand excluded by PLIPNAG.21: 2 residues within 4Å:- Chain A: I.673, N.675
Ligand excluded by PLIPNAG.22: 2 residues within 4Å:- Chain A: N.695, Y.759
Ligand excluded by PLIPNAG.23: 3 residues within 4Å:- Chain A: E.646, V.647, N.648
Ligand excluded by PLIPNAG.26: 3 residues within 4Å:- Chain B: L.159, V.211, N.212
Ligand excluded by PLIPNAG.27: 2 residues within 4Å:- Chain B: A.448, N.449
Ligand excluded by PLIPNAG.28: 1 residues within 4Å:- Chain B: N.713
Ligand excluded by PLIPNAG.29: 1 residues within 4Å:- Chain B: N.787
Ligand excluded by PLIPNAG.30: 4 residues within 4Å:- Chain B: A.932, A.933, N.936, G.940
Ligand excluded by PLIPNAG.31: 3 residues within 4Å:- Chain B: V.1192, N.1193, M.1197
Ligand excluded by PLIPNAG.32: 3 residues within 4Å:- Chain B: I.673, T.674, N.675
Ligand excluded by PLIPNAG.33: 3 residues within 4Å:- Chain B: E.646, V.647, N.648
Ligand excluded by PLIPNAG.34: 2 residues within 4Å:- Chain B: V.1222, N.1223
Ligand excluded by PLIPNAG.35: 3 residues within 4Å:- Chain C: N.137, N.171, T.196
Ligand excluded by PLIPNAG.36: 1 residues within 4Å:- Chain C: N.212
Ligand excluded by PLIPNAG.37: 2 residues within 4Å:- Chain C: P.446, N.449
Ligand excluded by PLIPNAG.38: 1 residues within 4Å:- Chain C: N.713
Ligand excluded by PLIPNAG.39: 1 residues within 4Å:- Chain C: N.787
Ligand excluded by PLIPNAG.40: 2 residues within 4Å:- Chain C: N.695, Y.759
Ligand excluded by PLIPNAG.41: 3 residues within 4Å:- Chain C: E.646, V.647, N.648
Ligand excluded by PLIPNAG.42: 3 residues within 4Å:- Chain C: A.932, N.936, G.940
Ligand excluded by PLIPNAG.43: 2 residues within 4Å:- Chain C: V.1222, N.1223
Ligand excluded by PLIP- 3 x 8Z9: Sapienic acid(Non-covalent)
8Z9.24: 13 residues within 4Å:- Chain A: I.345, M.372, L.375, I.379, A.391, Y.395, I.402, L.441, L.603, L.605
- Chain B: N.421, L.422, G.423
8 PLIP interactions:7 interactions with chain A, 1 interactions with chain B- Hydrophobic interactions: A:I.345, A:L.375, A:I.379, A:I.402, A:L.441, A:L.603, A:L.605
- Hydrogen bonds: B:L.422
8Z9.25: 12 residues within 4Å:- Chain A: V.415, N.421, L.422
- Chain C: F.370, M.372, M.376, I.379, A.381, A.391, I.394, L.441, L.603
9 PLIP interactions:7 interactions with chain C, 2 interactions with chain A- Hydrophobic interactions: C:F.370, C:I.379, C:A.381, C:I.394, C:I.394, C:L.441, C:L.603, A:V.415
- Hydrogen bonds: A:L.422
8Z9.44: 13 residues within 4Å:- Chain B: M.372, L.375, M.376, I.379, A.381, A.391, I.394, Y.395, L.441, L.603
- Chain C: N.421, L.422, G.423
10 PLIP interactions:3 interactions with chain C, 7 interactions with chain B- Hydrophobic interactions: C:N.421, B:L.375, B:L.375, B:I.379, B:A.381, B:L.441, B:L.603
- Hydrogen bonds: C:L.422, C:G.423, B:Y.395
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Bangaru, S. et al., Structural mapping of antibody landscapes to human betacoronavirus spike proteins. Sci Adv (2022)
- Release Date
- 2022-05-04
- Peptides
- Spike protein: ABC
Human polyclonal Fab model with polyalanine backbone - Heavy chain: DE - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
JB
AC
BD
HE
L
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-2-mer
- Ligands
- 13 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 27 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x 8Z9: Sapienic acid(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Bangaru, S. et al., Structural mapping of antibody landscapes to human betacoronavirus spike proteins. Sci Adv (2022)
- Release Date
- 2022-05-04
- Peptides
- Spike protein: ABC
Human polyclonal Fab model with polyalanine backbone - Heavy chain: DE - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
JB
AC
BD
HE
L